Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats

Journal of Radiation Research

Volumn 55, Issue 4, 2014, Pages 665-673

  Imaeda, Masumi ^a   Ishikawa, Hitoshi ^b   Yoshida, Yukari ^a   Takahashi, Takeo ^c   Ohkubo, Yu ^a   Musha, Atsushi ^a   Komachi, Mayumi ^a   Nakazato, Yoichi ^d   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d Hidaka Hospital   (Japan)

Author keywords

alpha smooth muscle actin; apoptosis; liver fibrosis; radiation induced liver injury; transforming growth factor beta 1

Indexed keywords

CELL DEATH; CELL PROLIFERATION; CONTROLLED DRUG DELIVERY; IRRADIATION; MUSCLE; PROTEINS; RADIATION; RADIOTHERAPY; RATS;

ALPHA SMOOTH MUSCLE ACTIN; CONTROL GROUPS; INTRA-OPERATIVE; LIVER FIBROSIS; LIVER INJURIES; RADIATION-INDUCED; RADIATION-INDUCED LIVER INJURY; SMOOTH MUSCLE ACTINS; TRANSFORMING GROWTH FACTOR-BETA 1; TRANSFORMING GROWTH FACTORS;

DISEASES;

ACTIN; SMOOTH MUSCLE ACTIN, RAT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; APOPTOSIS; CELL PROLIFERATION; DISEASE COURSE; EXPERIMENTAL RADIATION INJURY; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; PATHOLOGY; RADIATION RESPONSE; RAT; WISTAR RAT;

ACTINS; ANIMALS; APOPTOSIS; CELL PROLIFERATION; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, RADIATION; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LIVER; LIVER CIRRHOSIS; MALE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84905256885     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rru005     Document Type: Article

References (29)

1. Takayama T, Sekine T, Makuuchi M et al. Adoptive immuno-therapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000;356:802-7.
2. Arii S, Yamaoka S, Futagawa S et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000:32:1224-9.
3. Lencioni R, Pinto F, Armillotta N et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997;7:514-9.
4. Rossi S, Di Stasi M, Buscarini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-68.
5. Lawrence TS, Robertson JM, Anscher MS et al. Hepatic tox-icity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995;31:1237-48.
6. Liang SX, Zhu XD, Xu ZY et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 2006;65:426-34.
7. Bujold A, Massey CA, Kim JJ et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 2013;31:1631-9.
8. Jang WI, Kim MS, Bae SH et al. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma. Radiat Oncol 2013;8:250.
9. Kato H, Tsujii H, Miyamoto T et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004;8:1468-76.
10. Mizumoto M, Okumura T, Hashimoto T et al. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2012;8:e529-35.
11. Takeda A, Oku Y, Sanuki N et al. Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma. Radiother Oncol 2012;104:374-8.
12. Kim TH, Kim DY, Park JW et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007;67: 225-31.
13. Finkelstein JN, Johnston CJ, Baggs R et al. Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 1994;28:621-31.
14. Katoh H, Ishikawa H, Hasegawa M et al. Protective effect of urinary trypsin inhibitor on the development of radiation-induced lung fibrosis in mice. J Radiat Res 2010;51: 325-32.
15. Hakenjos L, Bamberg M, Rodemann HP. TGF-beta 1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol 2000;76: 503-9.
16. Du SS, Qiang M, Zenq ZC et al. Radiation-induced liver fibro-sis is mitigated by gene therapy inhibiting transforming growth factor-β signaling in the rat. Int J Radiat Oncol Biol Phys 2010;78:1513-23.
17. Seong J, Kim SH, Chung EJ et al. Early alteration in TGF-β mRNA expression in irradiated rat liver. Int J Radiat Oncol Biol Phys 2000;46:639-43.
18. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
19. Chung SI, Seong J, Park YN et al. Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats. J Radiat Res 2010;51:643-50.
20. Chi CH, Liu IL, Lo BS et al. Hepatocyte growth factor gene therapy prevents radiation-induced liver damage. World J Gastroenterol 2005;11:1496-502.
21. Geraci JP, Mariano MS. Radiation hepatology of the rat: association of the production of prostacyclin with radiation-induced hepatic fibrosis. Radiat Res 1996;145:93-7.
22. Ren ZG, Zhao JD, Gu K et al. Hepatic proliferation after partial liver irradiation in Sprague-Dawley rats. Mol Biol Rep 2012;39:3829-36.
23. Geraci JP, Mariano MS. Radiation hepatology of the rat: paren-chymal and nonparenchymal cell injury. Radiat Res 1993;136: 205-13.
24. Mustoe TA, Pierce GF, Thomason A et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 1987;237:1333-6.
25. Misseri R, Rink RC, Meldrum DR et al. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res 2004;119:149-59.
26. Nouchi T, Tanaka Y, Tsukada T et al. Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis. Liver 1991;11:100-5.
27. Chang XM, Chang Y, Jia A. Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-beta1 and alpha-smooth muscle actin in rats with hepatic fibro-sis. World J Gastroenterol 2005;11:2634-6.
28. Saito S, Murase K. Detection and early phase assessment of radiation-induced lung injury in mice using micro-CT. PLOS ONE 2012;7:e45960.
29. Verhaegen F, Granton P, Tryggestad E. Small animal radiotherapy research platforms. Phys Med Biol 2011;56: R55-83.